The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s ...
Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician
These include the β-2 agonist, clenbuterol (which is additionally used as an anorectic agent to reduce body fat), human growth hormone (HGH) and insulin/insulin-like growth factors. Other growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback